April 5, 2017
Heptares trigers milestone payment from AstraZeneca
Sosei Group Corporation’s subsidiary Heptares Therapeutics got milestone payment from AstraZeneca for working together on an immuno-oncology project.
Pharmaceuticals, Biotechnology and Life Sciences
Sosei Group Corporation’s subsidiary Heptares Therapeutics got milestone payment from AstraZeneca for working together on an immuno-oncology project.